Skip to content
Clinivis
Demonstration workspace · synthetic patients · supports, and does not replace, professional clinical judgement
Panel
TA

Thomas Adeyemi

High · 54

Tom · 63M · DOB 17 May 1963 · MRN RN-62844

COPD GOLD D after a steroid-treated exacerbation. AF on warfarin, and untreated steroid-related bone risk.

Respiratory clinic

Allergies: Aspirin (wheeze)

For full active treatment

INR 3.4 on prednisolone

Steroids potentiate warfarin. Recheck before the weekend.

Repeated oral steroids, no bone protection

NICE: consider bone protection after recurrent courses.

Aspirin allergy

Do not use dual antiplatelet or NSAID analgesia.

Clinical parameters

INR

3.4

Ref 2.0–3.0

Eosinophils

0.32×10⁹/L

Ref 0.0–0.4

CRP

18mg/L

Ref <5

Organ risk

Conditions

COPD GOLD D

FEV1 42% · 2 exacerbations/year

2017

Atrial fibrillation

2020-09

Osteoporosis risk

Repeated oral steroids

2025

Ex-smoker

40 pack years · quit 2019

2019

Care team

Dr Fiona Bell

Respiratory

Dr Amara Okonkwo

Clinical pharmacology

Luis Romero

Pulmonary rehab

Next encounter

INR recheck

Wed 23 Sep · 16:00

Anticoagulation desk · Anticoag clinic